Michael C. Quirk - Chief Scientific Officer and Interim Head of R&D at Sage Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer and Interim Head of R&D
Stock Symbol
SAGE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael C. Quirk since 10/6/2024

Holdings reported by Michael C. Quirk for Sage Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $7.79 Jul 31, 2025 Direct
S 4K Apr 1, 2025 Direct Common Stock
Stock Option (Right to Buy) 0 Jul 31, 2025 Direct Common Stock

Transactions reported by Michael C. Quirk for Sage Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.